Condition: Migraine Without Aura · Migraine With Aura · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
In this study,189 adult migraine patients aged 18-65 years (diagnosed with migraine without aura and/or migraine with aura, with at least a 1-year history)will be collected to evaluate the efficacy, safety and tolerability of Tizanidine Hydrochloride in preventing migraine attacks in episodic migraine in adults.
This description comes directly from the study's public registry record.
Kaiming Liu, MD & PHD · +8615068862055 · 2314411@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Affiliated Hospital of Southwest Medical University | Luzhou, Sichuan, China | Not Yet Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| The Second Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| Zhejiang Provincial People's Hospital | Hangzhou, Zhejiang, China | Not Yet Recruiting |
| The First Hospital of Jiaxing | Jiaxing, Zhejiang, China | Recruiting |
| Affiliated Hospital of Shaoxing University | Shaoxing, Zhejiang, China | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05484349